HEADER HYDROLASE 20-OCT-00 1G2M
TITLE FACTOR XA INHIBITOR COMPLEX
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: COAGULATION FACTOR X;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: CATALYTIC DOMAIN;
COMPND 5 EC: 3.4.21.6;
COMPND 6 MOL_ID: 2;
COMPND 7 MOLECULE: COAGULATION FACTOR X;
COMPND 8 CHAIN: B;
COMPND 9 FRAGMENT: DES-GLA FRAGMENT;
COMPND 10 EC: 3.4.21.6
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 OTHER_DETAILS: BLOOD SERUM;
SOURCE 6 MOL_ID: 2;
SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 8 ORGANISM_COMMON: HUMAN;
SOURCE 9 ORGANISM_TAXID: 9606;
SOURCE 10 OTHER_DETAILS: BLOOD SERUM
KEYWDS BLOOD COAGULATION, FACTOR XA, INHIBITOR COMPLEXES, SERINE PROTEINASE,
KEYWDS 2 BLOOD COAGULATION CASCADE, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR H.NAR
REVDAT 4 13-NOV-24 1G2M 1 REMARK LINK
REVDAT 3 24-FEB-09 1G2M 1 VERSN
REVDAT 2 01-APR-03 1G2M 1 JRNL
REVDAT 1 20-OCT-01 1G2M 0
JRNL AUTH H.NAR,M.BAUER,A.SCHMID,J.M.STASSEN,W.WIENEN,H.W.PRIEPKE,
JRNL AUTH 2 I.K.KAUFFMANN,U.J.RIES,N.H.HAUEL
JRNL TITL STRUCTURAL BASIS FOR INHIBITION PROMISCUITY OF DUAL SPECIFIC
JRNL TITL 2 THROMBIN AND FACTOR XA BLOOD COAGULATION INHIBITORS.
JRNL REF STRUCTURE V. 9 29 2001
JRNL REFN ISSN 0969-2126
JRNL PMID 11342132
JRNL DOI 10.1016/S0969-2126(00)00551-7
REMARK 2
REMARK 2 RESOLUTION. 3.02 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNX 2000
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS
REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,
REMARK 3 : YIP,DZAKULA)
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.02
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.51
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 944658.800
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.0
REMARK 3 NUMBER OF REFLECTIONS : 6609
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.218
REMARK 3 R VALUE (WORKING SET) : 0.218
REMARK 3 FREE R VALUE : 0.278
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700
REMARK 3 FREE R VALUE TEST SET COUNT : 311
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.016
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 6623
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.50
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 960
REMARK 3 BIN R VALUE (WORKING SET) : 0.2820
REMARK 3 BIN FREE R VALUE : 0.3940
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 43
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.060
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2267
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 33
REMARK 3 SOLVENT ATOMS : 0
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 57.40
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.90
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.29000
REMARK 3 B22 (A**2) : -3.04000
REMARK 3 B33 (A**2) : 1.76000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33
REMARK 3 ESD FROM SIGMAA (A) : 0.42
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.49
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.72
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.006
REMARK 3 BOND ANGLES (DEGREES) : 1.400
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.40
REMARK 3 IMPROPER ANGLES (DEGREES) : 1.090
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM
REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 4 : ION.PARAM
REMARK 3 PARAMETER FILE 5 : PARR110.PRO
REMARK 3 PARAMETER FILE 6 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP
REMARK 3 TOPOLOGY FILE 3 : WATER.TOP
REMARK 3 TOPOLOGY FILE 4 : ION.TOP
REMARK 3 TOPOLOGY FILE 5 : TOPR110.PRO
REMARK 3 TOPOLOGY FILE 6 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1G2M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-NOV-00.
REMARK 100 THE DEPOSITION ID IS D_1000012156.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 21-JAN-98
REMARK 200 TEMPERATURE (KELVIN) : 293
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6623
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4
REMARK 200 DATA REDUNDANCY : 2.600
REMARK 200 R MERGE (I) : 0.12200
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 45.85
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.70000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.85000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.60000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.85000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.70000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.60000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2740 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 13650 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ASP B 346
REMARK 465 GLY B 347
REMARK 465 ASP B 348
REMARK 465 GLN B 349
REMARK 465 CYS B 350
REMARK 465 GLU B 351
REMARK 465 THR B 352
REMARK 465 SER B 353
REMARK 465 PRO B 354
REMARK 465 CYS B 355
REMARK 465 GLN B 356
REMARK 465 ASN B 357
REMARK 465 GLN B 358
REMARK 465 GLY B 359
REMARK 465 LYS B 360
REMARK 465 CYS B 361
REMARK 465 LYS B 362
REMARK 465 ASP B 363
REMARK 465 GLY B 364
REMARK 465 LEU B 365
REMARK 465 GLY B 366
REMARK 465 GLU B 367
REMARK 465 TYR B 368
REMARK 465 THR B 369
REMARK 465 CYS B 370
REMARK 465 THR B 371
REMARK 465 CYS B 372
REMARK 465 LEU B 373
REMARK 465 GLU B 374
REMARK 465 GLY B 375
REMARK 465 PHE B 376
REMARK 465 GLU B 377
REMARK 465 GLY B 378
REMARK 465 LYS B 379
REMARK 465 ASN B 380
REMARK 465 CYS B 381
REMARK 465 GLU B 382
REMARK 465 LEU B 383
REMARK 465 PHE B 384
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLU A 74 CG CD OE1 OE2
REMARK 470 GLN A 75 CG CD OE1 NE2
REMARK 470 ASN B 405 CG OD1 ND2
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 ARG A 63 CB CG CD NE CZ NH1 NH2
REMARK 480 ARG A 150 CB CG CD NE CZ NH1 NH2
REMARK 480 LYS A 243 NZ
REMARK 480 ARG A 245 O CB CG CD NE CZ NH1
REMARK 480 ARG A 245 NH2 OXT
REMARK 480 LYS B 387 CB CG CD CE NZ
REMARK 480 LEU B 391 CB CG CD1 CD2
REMARK 480 ASP B 392 OD1 OD2
REMARK 480 HIS B 401 CG ND1 CD2 CE1 NE2
REMARK 480 GLU B 402 OE2
REMARK 480 GLU B 403 CG CD OE1 OE2
REMARK 480 GLN B 404 CB CG CD OE1 NE2
REMARK 480 ASN B 405 CA C O CB
REMARK 480 ARG B 413 NH2
REMARK 480 ASP B 419 OD1 OD2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ALA A 128 N - CA - C ANGL. DEV. = -18.8 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 48 -167.25 -163.73
REMARK 500 GLN A 61 21.45 -76.99
REMARK 500 ALA A 61A 134.87 -170.79
REMARK 500 GLU A 74 -77.14 -76.34
REMARK 500 GLU A 77 30.30 -81.34
REMARK 500 ASN A 92 -8.45 -58.42
REMARK 500 PRO A 124 -155.37 -93.21
REMARK 500 TRP A 127 72.19 90.43
REMARK 500 ALA A 128 -69.36 166.70
REMARK 500 SER A 130 138.45 106.99
REMARK 500 THR A 131 -58.86 77.59
REMARK 500 PHE A 141 50.52 -103.81
REMARK 500 HIS A 145 -1.43 -152.43
REMARK 500 GLU A 147 117.35 71.28
REMARK 500 ASP A 189 152.86 178.26
REMARK 500 LYS A 204 -75.83 72.89
REMARK 500 ASP A 205 -10.61 -146.71
REMARK 500 VAL A 213 108.92 -53.23
REMARK 500 SER A 214 -71.10 -97.27
REMARK 500 THR A 244 107.77 77.50
REMARK 500 LYS B 387 177.35 174.35
REMARK 500 LEU B 388 112.43 86.50
REMARK 500 ASP B 392 57.41 -175.14
REMARK 500 ASN B 393 17.97 57.93
REMARK 500 GLN B 398 -116.12 -139.21
REMARK 500 GLN B 404 -73.18 70.70
REMARK 500 ASN B 405 -18.40 -152.46
REMARK 500 VAL B 408 97.94 53.91
REMARK 500 LYS B 422 -45.66 -135.17
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA A 999 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP A 70 OD1
REMARK 620 2 ASN A 72 O 76.5
REMARK 620 3 GLN A 75 O 161.4 84.9
REMARK 620 4 GLU A 77 OE1 117.6 106.6 66.0
REMARK 620 5 GLU A 80 OE1 78.0 134.1 117.3 119.0
REMARK 620 6 GLU A 80 OE2 109.8 173.0 88.6 68.1 51.8
REMARK 620 N 1 2 3 4 5
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 999
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R11 A 1
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1G2L RELATED DB: PDB
REMARK 900 1G2L IS FACTOR XA INHIBITOR COMPLEX.
DBREF 1G2M A 16 245 UNP P00742 FA10_HUMAN 235 469
DBREF 1G2M B 385 439 UNP P00742 FA10_HUMAN 86 179
SEQRES 1 A 235 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO
SEQRES 2 A 235 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE
SEQRES 3 A 235 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR
SEQRES 4 A 235 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL
SEQRES 5 A 235 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY
SEQRES 6 A 235 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN
SEQRES 7 A 235 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL
SEQRES 8 A 235 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL
SEQRES 9 A 235 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER
SEQRES 10 A 235 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE
SEQRES 11 A 235 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU
SEQRES 12 A 235 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS
SEQRES 13 A 235 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE
SEQRES 14 A 235 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN
SEQRES 15 A 235 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP
SEQRES 16 A 235 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY
SEQRES 17 A 235 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL
SEQRES 18 A 235 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR
SEQRES 19 A 235 ARG
SEQRES 1 B 94 ASP GLY ASP GLN CYS GLU THR SER PRO CYS GLN ASN GLN
SEQRES 2 B 94 GLY LYS CYS LYS ASP GLY LEU GLY GLU TYR THR CYS THR
SEQRES 3 B 94 CYS LEU GLU GLY PHE GLU GLY LYS ASN CYS GLU LEU PHE
SEQRES 4 B 94 THR ARG LYS LEU CYS SER LEU ASP ASN GLY ASP CYS ASP
SEQRES 5 B 94 GLN PHE CYS HIS GLU GLU GLN ASN SER VAL VAL CYS SER
SEQRES 6 B 94 CYS ALA ARG GLY TYR THR LEU ALA ASP ASN GLY LYS ALA
SEQRES 7 B 94 CYS ILE PRO THR GLY PRO TYR PRO CYS GLY LYS GLN THR
SEQRES 8 B 94 LEU GLU ARG
HET CA A 999 1
HET R11 A 1 32
HETNAM CA CALCIUM ION
HETNAM R11 4-{[1-METHYL-5-(2-METHYL-BENZOIMIDAZOL-1-YLMETHYL)-1H-
HETNAM 2 R11 BENZOIMIDAZOL-2-YLMETHYL]-AMINO}-BENZAMIDINE
FORMUL 3 CA CA 2+
FORMUL 4 R11 C25 H25 N7
HELIX 1 1 ALA A 55 GLN A 61 5 7
HELIX 2 2 ASP A 164 SER A 172 1 9
HELIX 3 3 PHE A 234 LYS A 243 1 10
HELIX 4 4 ASP B 392 CYS B 396 5 5
SHEET 1 A 7 ALA A 81 LYS A 90 0
SHEET 2 A 7 LYS A 65 VAL A 68 -1 N VAL A 66 O HIS A 83
SHEET 3 A 7 GLN A 30 ILE A 34 -1 O LEU A 32 N ARG A 67
SHEET 4 A 7 GLY A 40 ILE A 46 -1 N PHE A 41 O LEU A 33
SHEET 5 A 7 TYR A 51 THR A 54 -1 N LEU A 53 O THR A 45
SHEET 6 A 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54
SHEET 7 A 7 ALA A 81 LYS A 90 -1 N GLU A 86 O ARG A 107
SHEET 1 B 8 GLN A 20 GLU A 21 0
SHEET 2 B 8 LYS A 156 VAL A 163 -1 N MET A 157 O GLN A 20
SHEET 3 B 8 MET A 180 ALA A 183 -1 O CYS A 182 N VAL A 163
SHEET 4 B 8 GLY A 226 LYS A 230 -1 O GLY A 226 N ALA A 183
SHEET 5 B 8 THR A 206 GLY A 216 -1 O ILE A 212 N THR A 229
SHEET 6 B 8 PRO A 198 PHE A 203 -1 N HIS A 199 O GLY A 211
SHEET 7 B 8 THR A 135 GLY A 140 -1 N ILE A 137 O VAL A 200
SHEET 8 B 8 LYS A 156 VAL A 163 -1 O LYS A 156 N GLY A 140
SHEET 1 C 2 PHE B 399 CYS B 400 0
SHEET 2 C 2 CYS B 409 SER B 410 -1 N SER B 410 O PHE B 399
SHEET 1 D 2 TYR B 415 LEU B 417 0
SHEET 2 D 2 CYS B 424 PRO B 426 -1 N ILE B 425 O THR B 416
SSBOND 1 CYS A 22 CYS A 27 1555 1555 2.04
SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.02
SSBOND 3 CYS A 122 CYS B 432 1555 1555 2.02
SSBOND 4 CYS A 168 CYS A 182 1555 1555 2.03
SSBOND 5 CYS A 191 CYS A 220 1555 1555 2.03
SSBOND 6 CYS B 389 CYS B 400 1555 1555 2.03
SSBOND 7 CYS B 396 CYS B 409 1555 1555 2.03
SSBOND 8 CYS B 411 CYS B 424 1555 1555 2.02
LINK OD1 ASP A 70 CA CA A 999 1555 1555 2.42
LINK O ASN A 72 CA CA A 999 1555 1555 2.18
LINK O GLN A 75 CA CA A 999 1555 1555 2.57
LINK OE1 GLU A 77 CA CA A 999 1555 1555 3.36
LINK OE1 GLU A 80 CA CA A 999 1555 1555 2.80
LINK OE2 GLU A 80 CA CA A 999 1555 1555 1.76
SITE 1 AC1 5 ASP A 70 ASN A 72 GLN A 75 GLU A 77
SITE 2 AC1 5 GLU A 80
SITE 1 AC2 14 HIS A 57 THR A 98 TYR A 99 PHE A 174
SITE 2 AC2 14 ASP A 189 ALA A 190 CYS A 191 SER A 195
SITE 3 AC2 14 SER A 214 TRP A 215 GLY A 216 GLY A 218
SITE 4 AC2 14 CYS A 220 GLY A 226
CRYST1 57.400 73.200 79.700 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017422 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013661 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012547 0.00000